title: To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator.
abstract: Nuclear factor κB (NFκB) is a transcription factor that plays an important role in carcinogenesis as well as in the regulation of inflammatory response. NFκB is constitutively expressed in tumours where it induces the expression of genes which promote cell proliferation, apoptotic events, angiogenesis, invasion and metastasis. Furthermore, many cancer cells show aberrant or constitutive NFκB activation that mediates resistance to chemo- and radio-therapy. Therefore, the inhibition of NFκB activity appears a potential therapeutic strategy for cancer treatment. In this review, we focus on the role of NFκB in carcinogenesis and summarize actual inhibitors of NFκB that could be potential therapeutic target in cancer therapy.
authors.affiliation: Department of Clinical Medicine, Cardiovascular and Immunological Science, Federico II University of Naples, Italy.
authors.forename: Daniela
authors.initials: D
authors.lastname: Sorriento
authors.forename: Maddalena
authors.initials: M
authors.lastname: Illario
authors.forename: Rosa
authors.initials: R
authors.lastname: Finelli
authors.forename: Guido
authors.initials: G
authors.lastname: Iaccarino
keywords: GRK5; IκB; cancer; transcription factors
references.citation: Semin Cancer Biol. 2003 Apr;13(2):107-14
references.pmid: 12654254
references.citation: J Biol Chem. 2001 Feb 2;276(5):3650-9
references.pmid: 11062239
references.citation: Cancer Res. 2003 Jul 1;63(13):3560-6
references.pmid: 12839942
references.citation: J Biol Chem. 1998 Apr 3;273(14):7787-90
references.pmid: 9525868
references.citation: Cancer Metastasis Rev. 1999;18(3):345-57
references.pmid: 10721489
references.citation: Exp Biol Med (Maywood). 2006 Jan;231(1):20-7
references.pmid: 16380641
references.citation: Mol Cell Biol. 1999 Apr;19(4):2690-8
references.pmid: 10082535
references.citation: Cytokine Growth Factor Rev. 2002 Apr;13(2):135-41
references.pmid: 11900989
references.citation: J Biol Chem. 2003 Jun 13;278(24):21631-8
references.pmid: 12690099
references.citation: Cancer Res. 2000 Oct 1;60(19):5334-9
references.pmid: 11034066
references.citation: J Invest Dermatol. 2001 Aug;117(2):360-4
references.pmid: 11511316
references.citation: Front Biosci. 2008 May 01;13:5094-107
references.pmid: 18508572
references.citation: Cell. 2002 Feb 22;108(4):475-87
references.pmid: 11909519
references.citation: Oncogene. 1999 Nov 22;18(49):6938-47
references.pmid: 10602468
references.citation: Nature. 2004 Sep 23;431(7007):405-6
references.pmid: 15385993
references.citation: Mol Cell Biol. 1997 Jul;17(7):4015-23
references.pmid: 9199336
references.citation: Cancer Res. 1998 May 15;58(10):2217-23
references.pmid: 9605769
references.citation: IET Syst Biol. 2009 Sep;3(5):356-67
references.pmid: 21028926
references.citation: Clin Cancer Res. 2005 Apr 1;11(7):2459-65
references.pmid: 15814620
references.citation: Clin Cancer Res. 2000 Jun;6(6):2573-81
references.pmid: 10873114
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10057-62
references.pmid: 9294162
references.citation: Hypertension. 2010 Oct;56(4):696-704
references.pmid: 20660817
references.citation: Blood. 1989 Apr;73(5):1242-6
references.pmid: 2539214
references.citation: Oncologist. 2003;8(6):508-13
references.pmid: 14657528
references.citation: Science. 1999 Apr 9;284(5412):321-5
references.pmid: 10195897
references.citation: Cancer Res. 2003 Jul 15;63(14):4181-7
references.pmid: 12874024
references.citation: Nature. 2005 Jul 28;436(7050):518-24
references.pmid: 16049480
references.citation: Cancer Res. 2002 Feb 1;62(3):932-40
references.pmid: 11830554
references.citation: Mol Cell Biol. 1999 Sep;19(9):5923-9
references.pmid: 10454539
references.citation: Cell. 1998 May 29;93(5):705-16
references.pmid: 9630216
references.citation: Curr Opin Genet Dev. 1999 Apr;9(2):140-7
references.pmid: 10322133
references.citation: Clin Cancer Res. 2005 Jan 1;11(1):28-40
references.pmid: 15671525
references.citation: Cancer Res. 1996 Dec 1;56(23):5499-505
references.pmid: 8968107
references.citation: Oncogene. 2004 Dec 9;23(57):9247-58
references.pmid: 15489888
references.citation: Nature. 1998 Nov 5;396(6706):77-80
references.pmid: 9817203
references.citation: Eur J Cancer. 1999 Sep;35(9):1374-80
references.pmid: 10658530
references.citation: J Biol Chem. 2004 Dec 24;279(52):54610-9
references.pmid: 15475567
references.citation: Nat Cell Biol. 2006 Dec;8(12):1321-3
references.pmid: 17139281
references.citation: Mol Carcinog. 2007 May;46(5):402-13
references.pmid: 17186550
references.citation: Immunity. 1999 Apr;10(4):421-9
references.pmid: 10229185
references.citation: Oncogene. 1995 Sep 7;11(5):999-1003
references.pmid: 7675461
references.citation: Nature. 2001 Jun 28;411(6841):1017-21
references.pmid: 11429595
references.citation: Oncogene. 2003 Apr 3;22(13):1955-64
references.pmid: 12673201
references.citation: Am J Pathol. 2001 Aug;159(2):387-97
references.pmid: 11485895
references.citation: Cancer Res. 2002 Feb 1;62(3):910-6
references.pmid: 11830551
references.citation: Annu Rev Immunol. 2004;22:891-928
references.pmid: 15032599
references.citation: Blood. 1989 Feb;73(2):517-26
references.pmid: 2783861
references.citation: Carcinogenesis. 2003 Sep;24(9):1515-24
references.pmid: 12844482
references.citation: Oncogene. 2006 Aug 7;25(34):4798-811
references.pmid: 16892092
references.citation: Cancer Lett. 2007 Oct 28;256(2):137-65
references.pmid: 17629396
references.citation: Curr Opin Genet Dev. 1996 Jun;6(3):334-42
references.pmid: 8791518
references.citation: Cancer Res. 1999 Sep 1;59(17):4446-52
references.pmid: 10485496
references.citation: Mol Carcinog. 1999 Oct;26(2):119-29
references.pmid: 10506755
references.citation: Mol Cancer. 2009 Nov 09;8:97
references.pmid: 19900276
references.citation: Cancer Treat Res. 2004;119:139-73
references.pmid: 15164877
references.citation: Oncogene. 2005 Jan 13;24(3):419-30
references.pmid: 15543232
references.citation: Cell. 2000 Oct 27;103(3):481-90
references.pmid: 11081634
references.citation: Ann Med. 2004;36(4):304-14
references.pmid: 15224657
references.citation: Nature. 1987 Oct 15-21;329(6140):630-2
references.pmid: 2443857
references.citation: J Biol Chem. 2001 Jun 22;276(25):22382-7
references.pmid: 11297551
references.citation: Semin Cell Dev Biol. 2004 Apr;15(2):177-82
references.pmid: 15209377
references.citation: Int J Biochem Cell Biol. 1997 Dec;29(12):1305-12
references.pmid: 9570129
references.citation: Cancer Res. 2000 Dec 1;60(23):6557-62
references.pmid: 11118032
references.citation: Cancer Cell. 2004 Sep;6(3):203-8
references.pmid: 15380510
references.citation: Oncogene. 2003 Jan 9;22(1):50-8
references.pmid: 12527907
references.citation: Nat Rev Genet. 2009 Apr;10(4):252-63
references.pmid: 19274049
references.citation: Mol Cell Biol. 2001 Jun;21(12):3964-73
references.pmid: 11359904
references.citation: Br J Cancer. 2010 Feb 16;102(4):639-44
references.pmid: 20087353
references.citation: Cell Death Differ. 2006 May;13(5):738-47
references.pmid: 16485028
references.citation: Ann Clin Lab Sci. 2005 Summer;35(3):251-8
references.pmid: 16081580
references.citation: J Biol Chem. 1997 Oct 3;272(40):25176-83
references.pmid: 9312130
references.citation: Int Immunol. 2002 Aug;14(8):905-16
references.pmid: 12147627
references.citation: Br J Cancer. 1995 Nov;72(5):1165-72
references.pmid: 7577463
references.citation: EMBO J. 2002 Aug 1;21(15):4104-13
references.pmid: 12145210
references.citation: Nat Med. 1999 Apr;5(4):412-7
references.pmid: 10202930
references.citation: Cancer Res. 2001 May 15;61(10):4160-8
references.pmid: 11358840
references.citation: Toxicology. 2002 Dec 27;181-182:131-41
references.pmid: 12505298
references.citation: Cancer Res. 2011 Mar 15;71(6):2183-92
references.pmid: 21406399
references.citation: Nat Rev Cancer. 2002 Apr;2(4):301-10
references.pmid: 12001991
references.citation: Am J Clin Pathol. 2001 Dec;116 Suppl:S97-107
references.pmid: 11993705
references.citation: J Biol Chem. 1999 Sep 17;274(38):27307-14
references.pmid: 10480951
references.citation: Cancer Res. 2003 Dec 1;63(23):8293-301
references.pmid: 14678988
references.citation: J Virol. 2003 May;77(9):5286-94
references.pmid: 12692230
references.citation: J Immunol. 2002 Jul 1;169(1):469-75
references.pmid: 12077278
references.citation: Nat Rev Immunol. 2003 Sep;3(9):745-56
references.pmid: 12949498
references.citation: J Immunol. 1993 Aug 15;151(4):1979-88
references.pmid: 8345191
references.citation: J Biol Chem. 1992 Aug 15;267(23):16288-91
references.pmid: 1644814
references.citation: Mol Cell Biol. 1997 Nov;17(11):6526-36
references.pmid: 9343416
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):863-7
references.pmid: 8430098
references.citation: Cancer Res. 1991 Aug 15;51(16):4476-80
references.pmid: 1868469
references.citation: Mol Cell Biol. 1999 Aug;19(8):5785-99
references.pmid: 10409765
references.citation: Gene. 2009 Apr 15;435(1-2):36-44
references.pmid: 19393188
references.citation: Eur J Haematol. 2005 Dec;75(6):485-91
references.pmid: 16313260
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: Leukemia. 2000 Dec;14(12):2149-58
references.pmid: 11187905
references.citation: J Clin Invest. 1997 Dec 15;100(12):2952-60
references.pmid: 9399940
references.citation: J Clin Invest. 1997 Dec 15;100(12):2961-9
references.pmid: 9399941
references.citation: Oncogene. 1999 Nov 22;18(49):6925-37
references.pmid: 10602467
references.citation: EMBO J. 2001 Dec 3;20(23):6805-15
references.pmid: 11726516
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2840-4
references.pmid: 7708734
references.citation: Prostate. 2002 Aug 1;52(3):183-200
references.pmid: 12111695
references.citation: Cell. 2002 Apr;109 Suppl:S81-96
references.pmid: 11983155
references.citation: Cancer Res. 2000 Jul 1;60(13):3477-83
references.pmid: 10910059
references.citation: Semin Cancer Biol. 1997 Apr;8(2):121-9
references.pmid: 9299590
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1605-21
references.pmid: 16889756
references.citation: Leuk Lymphoma. 1994 Jan;12(3-4):191-5
references.pmid: 7513220
references.citation: J Biol Chem. 2001 Mar 9;276(10):6893-6
references.pmid: 11145953
references.citation: Nature. 1997 Jul 10;388(6638):190-5
references.pmid: 9217161
references.citation: Clin Cancer Res. 1999 Jan;5(1):119-27
references.pmid: 9918209
references.citation: J Biol Chem. 2000 Mar 3;275(9):6067-70
references.pmid: 10692394
references.citation: J Immunol. 1998 Sep 15;161(6):2833-40
references.pmid: 9743343
references.citation: Leukemia. 2002 Jun;16(6):1053-68
references.pmid: 12040437
references.citation: Cancer Res. 1993 May 1;53(9):1982-5
references.pmid: 8481899
references.citation: Am J Cardiovasc Drugs. 2002;2(1):43-57
references.pmid: 14727998
references.citation: Nature. 2005 Jun 9;435(7043):752-3
references.pmid: 15944689
references.citation: Biochem Pharmacol. 2000 Oct 15;60(8):1085-9
references.pmid: 11007945
references.citation: Nat Rev Cancer. 2002 Mar;2(3):161-74
references.pmid: 11990853
references.citation: Postepy Hig Med Dosw. 2001;55(2):257-74
references.pmid: 11468973
references.citation: Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4263s-4265s
references.pmid: 15217971
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Science. 1996 Nov 1;274(5288):787-9
references.pmid: 8864120
references.citation: Cancer Res. 2002 Dec 1;62(23):6870-8
references.pmid: 12460901
references.citation: EMBO J. 1998 Apr 15;17(8):2215-23
references.pmid: 9545235
references.citation: Cancer Res. 1995 Oct 15;55(20):4581-5
references.pmid: 7553633
references.citation: Anticancer Res. 2004 Mar-Apr;24(2B):675-81
references.pmid: 15161011
references.citation: Annu Rev Immunol. 2000;18:621-63
references.pmid: 10837071
references.citation: Cancer Res. 2001 May 1;61(9):3770-4
references.pmid: 11325850
references.citation: J Exp Med. 1999 Jun 7;189(11):1839-45
references.pmid: 10359587
references.citation: Curr Mol Med. 2001 Jul;1(3):287-96
references.pmid: 11899077
references.citation: EMBO J. 1993 Feb;12(2):461-8
references.pmid: 8440237
references.citation: Mol Cell Biol. 2001 Aug;21(16):5299-305
references.pmid: 11463813
references.citation: J Immunol. 1989 Dec 1;143(11):3828-34
references.pmid: 2584719
references.citation: Biochem Pharmacol. 2004 Sep 15;68(6):1071-80
references.pmid: 15313403
references.citation: Cancer Res. 2001 Jul 1;61(13):4961-5
references.pmid: 11431324
references.citation: J Cell Sci. 2005 Aug 1;118(Pt 15):3487-500
references.pmid: 16079290
references.citation: Biofactors. 2007;29(1):19-35
references.pmid: 17611291
references.citation: Science. 1998 Sep 11;281(5383):1680-3
references.pmid: 9733516
references.citation: Nat Med. 2004 Jun;10(6):617-24
references.pmid: 15156202
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: Annu Rev Immunol. 1996;14:649-83
references.pmid: 8717528
references.citation: J Biol Chem. 1998 May 29;273(22):14008-14
references.pmid: 9593751
references.citation: J Biol Chem. 2000 Jan 21;275(3):1887-96
references.pmid: 10636889
references.citation: Nat Cell Biol. 2006 Dec;8(12):1369-75
references.pmid: 17128264
references.citation: Nature. 1997 May 15;387(6630):296-9
references.pmid: 9153395
references.citation: Nature. 2000 Nov 16;408(6810):307-10
references.pmid: 11099028
references.citation: Int J Dev Biol. 2004;48(5-6):489-96
references.pmid: 15349823
references.citation: Clin Cancer Res. 2001 May;7(5):1419-28
references.pmid: 11350913
references.citation: Blood. 2001 May 1;97(9):2798-807
references.pmid: 11313274
references.citation: Ann N Y Acad Sci. 2004 Dec;1030:162-9
references.pmid: 15659794
references.citation: Nat Rev Cancer. 2009 May;9(5):361-71
references.pmid: 19343034
references.citation: Immunity. 2001 Mar;14(3):217-30
references.pmid: 11290332
references.citation: J Biol Chem. 2002 Jan 11;277(2):1405-18
references.pmid: 11687592
references.citation: Oncogene. 2003 Nov 6;22(50):8137-44
references.pmid: 14603254